Luye Pharma Group Ltd Ordinary Shares - Class H LYPHF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.32
- Day Range
- $0.27–0.27
- 52-Week Range
- $0.20–0.40
- Bid/Ask
- $0.00 / $256,000.28
- Shares Outstanding
- 3.99B
- Market Cap
- $1.08B
- Volume/Avg
- 1M / 1M
Key Statistics
- Price/Earnings (Normalized)
- 70.39
- Price/Sales
- 1.56
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Luye Pharma Group Ltd is a China-based drug manufacturer that focuses on development, production, marketing and sale of pharmaceutical products. The company develops drugs related to diagnosing and treating cancer, the cardiovascular system, the alimentary tract, and the central nervous system. The company develops drugs for world-wide use in Asia, Europe, and the United States. The Group organizes its business segments by type of products. Oncology drugs, which derives maximum revenue; Cardiovascular system drugs; Alimentary tract and metabolism drugs; Central nervous system drugs; and others. Geographically, the group derives maximum revenue from Chinese Mainland, while it also has its presence in Asia (other than the Chinese mainland), European Union, and Other countries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 5,221
- Website
- https://www.luye.cn
Valuation
|
Metric
|
LYPHF
|
|---|---|
Price/Earnings (Normalized) | 70.39 |
Price/Book Value | 0.48 |
Price/Sales | 1.56 |
Price/Cash Flow | 7.65 |
Price/Earnings
LYPHF
Financial Strength
|
Metric
|
LYPHF
|
|---|---|
Quick Ratio | 1.15 |
Current Ratio | 1.45 |
Interest Coverage | 2.32 |
Quick Ratio
LYPHF
Profitability
|
Metric
|
LYPHF
|
|---|---|
Return on Assets (Normalized) | 1.21% |
Return on Equity (Normalized) | 2.67% |
Return on Invested Capital (Normalized) | 2.91% |
Return on Assets
LYPHF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|jNPh@K^& | LOCK|hc&>? | $67B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|$HLV?h@ | LOCK|Rfrj^ | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|cR%v#<F | LOCK|kfK | $41B | |||
| Zoetis Inc Class A
ZTS
| LOCK|>&Yxs!@$ | LOCK|#< | $31B | |||
| Viatris Inc
VTRS
| LOCK|Q$<#CXs | LOCK|?Vc | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|LC | LOCK|X%P | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|D@&F<b | LOCK|!pL | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|$>L&%R% | LOCK|R@< | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|C><?MF | LOCK|$v&! | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|WX>?&@h | LOCK|DPl | $2B |
United States